Company news
OraSure Technologies, Inc. news in 2024
OraSure Technologies, Inc.'s news releases, calls and decks from 2024, newest first.
OraSure Technologies Acquires Sherlock Biosciences
December 18, 2024
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
December 1, 2024
OraSure Reports Q3 ’24 Revenue of $39.9 Million
November 5, 2024
OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th
October 21, 2024
OraSure Technologies Elects Jack Kenny to the Board of Directors
September 8, 2024
OraSure Reports Q2 ’24 Revenue of $54.3 Million
August 5, 2024
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
July 21, 2024
OraSure Technologies Supports National HIV Testing Day
June 26, 2024
OraSure Reports Q1 ’24 Revenue of $54.1 Million
May 7, 2024
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
April 21, 2024
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
February 26, 2024
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
February 12, 2024
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
January 3, 2024
Calls in 2024
- Orasure Technologies (NASDAQ:OSUR) Q3 2024 Earnings Call
Nov 6, 2024
Transcript - Orasure Technologies (NASDAQ:OSUR) Q2 2024 Earnings Call
Aug 6, 2024
Transcript - Orasure Technologies (NASDAQ:OSUR) Q1 2024 Earnings Call
May 8, 2024
Transcript - Orasure Technologies (NASDAQ:OSUR) Q4 2023 Earnings Call
Feb 27, 2024
Transcript
Decks in 2024
- Merger or Acquisition (December 2024)
Merger or acquisition · 11 slides · Dec 19, 2024
- Merger or Acquisition (January 2024)
Merger or acquisition · 12 slides · Jan 4, 2024